FRAZIANO, MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 21.527
EU - Europa 3.035
AS - Asia 3.032
SA - Sud America 455
AF - Africa 115
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 28.209
Nazione #
US - Stati Uniti d'America 21.397
SG - Singapore 1.188
IT - Italia 626
CN - Cina 557
DE - Germania 425
RU - Federazione Russa 399
BR - Brasile 352
UA - Ucraina 278
IE - Irlanda 251
VN - Vietnam 243
FR - Francia 217
HK - Hong Kong 210
GB - Regno Unito 208
SE - Svezia 152
SA - Arabia Saudita 142
PL - Polonia 141
JP - Giappone 123
FI - Finlandia 103
IN - India 96
KR - Corea 90
CA - Canada 81
BD - Bangladesh 77
NL - Olanda 60
IR - Iran 42
PK - Pakistan 41
AR - Argentina 34
BE - Belgio 32
AU - Australia 30
ID - Indonesia 30
MX - Messico 30
JO - Giordania 29
ZA - Sudafrica 29
ES - Italia 28
TR - Turchia 28
IQ - Iraq 27
PH - Filippine 24
AT - Austria 22
EG - Egitto 20
EC - Ecuador 17
CH - Svizzera 16
ET - Etiopia 16
NG - Nigeria 16
CO - Colombia 14
CL - Cile 13
CZ - Repubblica Ceca 13
MY - Malesia 13
TH - Thailandia 11
TW - Taiwan 11
LT - Lituania 10
PT - Portogallo 9
UZ - Uzbekistan 9
IL - Israele 8
PE - Perù 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
GR - Grecia 7
KG - Kirghizistan 7
RO - Romania 7
TN - Tunisia 7
GH - Ghana 6
KE - Kenya 6
NO - Norvegia 6
EU - Europa 5
NZ - Nuova Zelanda 5
PY - Paraguay 5
ER - Eritrea 4
JM - Giamaica 4
MA - Marocco 4
NP - Nepal 4
RS - Serbia 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
OM - Oman 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
HN - Honduras 2
HU - Ungheria 2
KZ - Kazakistan 2
LI - Liechtenstein 2
LY - Libia 2
MD - Moldavia 2
PS - Palestinian Territory 2
QA - Qatar 2
SI - Slovenia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
GA - Gabon 1
Totale 28.194
Città #
Woodbridge 5.608
Wilmington 4.989
Houston 4.662
Singapore 692
Fairfield 642
Ann Arbor 548
Ashburn 532
Chandler 499
San Jose 422
Seattle 260
Jacksonville 246
Dublin 215
Beijing 203
Cambridge 190
Rome 190
Hong Kong 184
New York 180
Dearborn 164
Medford 161
Council Bluffs 152
Jeddah 131
Los Angeles 125
The Dalles 109
Kraków 99
Tokyo 89
Santa Clara 86
Lawrence 76
Ho Chi Minh City 69
Hanoi 66
Dallas 56
Milan 53
Moscow 52
São Paulo 51
Buffalo 49
Munich 46
Menlo Park 44
Mülheim 41
Hamburg 40
Helsinki 40
Orem 36
Lauterbourg 35
Boardman 33
Warsaw 33
San Diego 32
Amman 29
London 28
Philadelphia 28
Chicago 26
Frankfurt am Main 26
Montreal 26
Seoul 26
Brussels 25
Atlanta 24
Chennai 23
Phoenix 23
Nuremberg 22
Denver 20
Guangzhou 19
Jakarta 19
Toronto 19
Brooklyn 18
Hefei 18
Stockholm 18
Johannesburg 17
Mexico City 17
Mountain View 17
Cairo 16
Naples 16
North Bergen 16
Manchester 15
Mumbai 15
Redwood City 15
Amsterdam 14
Minneapolis 14
Poplar 14
Rio de Janeiro 14
Boston 12
Madrid 12
Norwalk 12
Belo Horizonte 11
Birmingham 11
Haiphong 11
San Francisco 11
San Mateo 11
Florence 10
Kunming 10
Lappeenranta 10
Palo Alto 10
Redondo Beach 10
Shanghai 10
Southampton 10
Brisbane 9
Central 9
Vienna 9
Zhengzhou 9
Baghdad 8
Columbus 8
Da Nang 8
Detroit 8
Falls Church 8
Totale 23.104
Nome #
Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307 670
Exploiting phages–bacteria co-evolution to overcome phage resistance and to ease the selection of new phage particles 586
B-Pred, a structure based B-cell epitopes prediction server 538
In vitro analysis of pyrogenicity and cytotoxicity profiles of flex sensors to be used to sense human joint postures 519
CD4-8- T-cells increase in MRL/lpr mice treated with thymic factors 519
A new Mycobacterium tuberculosis smooth colony reduces growth inside human macrophages and represses PDIM Operon gene expression. Does an heterogeneous population exist in intracellular mycobacteria? 515
Monosodium urate crystals promote innate anti-mycobacterial immunity and improve BCG efficacy as a vaccine against tuberculosis 485
Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages: early membrane modifications and intracellular mycobacterial viability 482
Mycobacterium tuberculosis may escape helper T cell recognition by infecting human fibroblasts 472
Dormant Mycobacterium tuberculosis fails to block phagosome maturation and shows unexpected capacity to stimulate specific human T lymphocytes 471
Atrial natriuretic factor inhibits mitogen-induced growth in aortic smooth muscle cells 465
The presence of antibodies against HIV peptides in the sera of alloimmune mice and thalassemic patients is due to a polyclonal activation mechanism 464
Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo 461
Natural lysophospholipids reduce Mycobacterium tuberculosis-induced cytotoxicity and induce anti-mycobacterial activity by a phagolysosome maturation-dependent mechanism in A549 type II alveolar epithelial cells 460
Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo 455
Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity 453
In vitro anti Mycobacterium tuberculosis H37Rv activity of Lannea acida A. Rich from Burkina Faso 451
Diagnosis of tuberculosis: Available technologies, limitations, and possibilities 450
Expansion of CCR5+ CD4+ T-lymphocytes in the course of active pulmonary tuberculosis 450
Compartmentalization of the redox environment in PC-12 neuronal cells 447
Batimastat reduces Mycobacterium tuberculosis-induced apoptosis in macrophages 445
Lysophosphatidic acid enhances antimycobacterial activity both in vitro and ex vivo 443
Effective anti-tumor immunity induced in mice by a two-step vaccination protocol 443
PE_PGRS30 is required for the full virulence of Mycobacterium tuberculosis 443
Asymmetric liposomes and uses in medical field thereof 439
Macrophage response to Mycobacterium tuberculosis during HIV infection: relationships between macrophage activation and apoptosis 435
Immunoregulatory compounds 433
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection 429
Induction of graft versus host disease in SCID mice by MRL/lpr cell transfer 428
Does sphingosine 1-phosphate play a protective role in the course of pulmonary tuberculosis? 425
Role of macrophage phospholipase D in natural and CpG-induced antimycobacterial activity 419
CpG oligodeoxynucleotides promote phospholipase D dependent phagolysosome maturation and intracellular mycobacterial killing in M. tuberculosis infected type II alveolar epithelial cells 415
Sphingosine 1-phosphate promotes antigen processing and presentation to CD4+ T cells in Mycobacterium tuberculosis-infected monocytes 411
Exploiting immunotherapy in Mycobacterium tuberculosis-infected mice: sphingosine 1-phosphate treatment results in a protective or detrimental effect depending on the stage of infection 410
CpG oligodeoxynucleotides induce Ca2+-dependent phospholipase D activity leading to phagolysosome maturation and intracellular mycobacterial growth inhibition in monocytes 407
Mycobacterial 19-kDa lipoprotein mediates Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages at early stages of infection 405
Comparison of IL-2- and IL-4-transfected B16-F10 cells with a novel oil-microemulsion adjuvant for B16-F10 whole cell tumour vaccine 399
Proinflammatory cytokines in the course of Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages 394
Molecular bases for the anti-HIV-1 effect of NO. Commentary 392
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection 390
Epitope specificity of anti-HIV antibodies in human and murine autoimmune diseases 389
Lysophosphatidic acid enhances antimycobacterial response during in vivo primary Mycobacterium tuberculosis infection 389
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection 389
Lack of 'tissue' transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRLIpr/Ipr mice 385
Induction of apoptosis and release of interleukin-1 beta by cell wall-associated 19-kDa lipoprotein during the course of mycobacterial infection 383
Nitric oxide inhibits the HIV-1 reverse transcriptase activity 382
Nitric oxide inhibits HIV-1 replication in human astrocytoma cells 367
Differential sensitivity of human monocytes and macrophages to ANP: a role of intracellular pH on reactive oxygen species production through the phospholipase involvement 365
Liposomes loaded with bioactive lipids enhance antibacterial innate immunity irrespective of drug resistance 361
Analysis of the shotgun expression library of the Mycobacterium tuberculosis genorne for immunodominant polypeptides: Potential use in serodiagnosis 357
Monocytes/macrophages in HIV infection and tuberculosis 344
Mycobacterium tuberculosis and human macrophage: the bacillus with "environment-sensing" 330
The RNA binding protein Sam68 controls T helper 1 differentiation and anti-mycobacterial response through modulation of miR-29 307
Adipocyte metabolism is improved by TNF receptor-targeting small RNAs identified from dried nuts 304
Characterization of vB_Kpn_F48, a Newly Discovered Lytic Bacteriophage for Klebsiella pneumoniae of Sequence Type 101 285
Hydroalcoholic extract from Origanum vulgare induces a combined anti-mycobacterial and anti-inflammatory response in innate immune cells 245
Preclinical study of a combined host- and pathogen directed approach based on bioactive liposomes and bacteriophages against Mycobacterium abscessus infection 238
First Case of Patient With Two Homozygous Mutations in MYD88 and CARD9 Genes Presenting With Pyogenic Bacterial Infections, Elevated IgE, and Persistent EBV Viremia 233
The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment 230
The urgent need for novel antimicrobial agents and strategies to fight antibiotic resistance 220
A method permissive to fixation and permeabilization for the multiparametric analysis of apoptotic and necrotic cell phenotype by flow cytometry 219
The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases 215
Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy 199
When PINK is a question: A possible evolutionary trade-off in the Galápagos Pink Land Iguana (Conolophus marthae) 192
Characterization of vb_stus_mmda13, a newly discovered bacteriophage infecting the agar-degrading species sphingomonas turrisvirgatae 187
Redox activation of ATM enhances GSNOR translation to sustain mitophagy and tolerance to oxidative stress 170
25-Hydroxyvitamin D Plasma Levels in Natural Populations of Pigmented and Partially Pigmented Land Iguanas from Galápagos (Conolophus spp.) 152
Combined host- and pathogen-directed therapy for the control of mycobacterium abscessus infection 140
Phage-resistance in Klebsiella pneumoniae clinical isolates may correlate to augmented clearance by phagocytes 136
Rifampicin-liposomes for mycobacterium abscessus infection treatment: intracellular uptake and antibacterial activity evaluation 135
Liposomes Loaded With Phosphatidylinositol 5-Phosphate Improve the Antimicrobial Response to Pseudomonas aeruginosa in Impaired Macrophages From Cystic Fibrosis Patients and Limit Airway Inflammatory Response 128
Phage Resistance Is Associated with Decreased Virulence in KPC-Producing Klebsiella pneumoniae of the Clonal Group 258 Clade II Lineage 125
Application of bacteriophages for human health: an old approach against contemporary “bad bugs” 120
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 119
Fighting MDR-Klebsiella pneumoniae infections by a combined host- and pathogen-directed therapeutic approach 118
Phage-resistance mechanism in KPC-producing Klebsiella pneumoniae of the clonal group 258 clade II lineage 118
Bioactive liposomes for the control of Mycobacterium abscessus infection. 115
CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance and immune homeostasis 114
Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages 112
Mucoadhesive Rifampicin-Liposomes for the Treatment of Pulmonary Infection by Mycobacterium abscessus: Chitosan or ε-Poly-L-Lysine Decoration 108
Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307 103
Phosphatidylserine liposomes reduce inflammatory response, mycobacterial viability and HIV replication in coinfected human macrophages 102
Immunization with mycobacterium tuberculosisantigens encapsulated in phosphatidylserine liposomes improves protection afforded by BCG 101
Phosphaditylserine liposomes as a possible candidate for the therapeutic management of Mycobacterium abscessus infection in CF patients 94
PMN-MDSC frequency discriminates active versus latent tuberculosis and could play a role in counteracting the immune-mediated lung damage in active disease 82
Evaluation of phages and liposomes as combination therapy to counteract Pseudomonas aeruginosa infection in wild-type and CFTR-null models 71
Phosphatidylinositol 5-Phosphate-Loaded Apoptotic Body-Like Liposomes for Mycobacterium abscessus Infection Management in Patients With Cystic Fibrosis 68
Editorial: Exploiting Novel Combined Host- and Pathogen-Directed Therapies for Combating Bacterial Multidrug Resistance 62
Phosphatidylserine liposomes induce a phagosome acidification-dependent and ROS-mediated intracellular killing of Mycobacterium abscessus in human macrophages 61
Phosphatidylserine liposomes for Mycobacterium abscessus infections management in people with cystic fibrosis non-eligible for CFTR modulators 21
Lytic bacteriophages against Klebsiella pneumoniae and their impact on bacterial virulence 21
Production and characterization of a phage-encoded capsular polysaccharide endoglycosidase targeting Sequence Type 307 Klebsiella pneumoniae strains 19
vB_KpM_GP-7: a novel myovirus targeting capsule-deficient, phage-resistant Klebsiella pneumoniae 16
Enhanced clearance of phage-resistant Klebsiella pneumoniae strains by the innate immune system 14
Phosphatidylinositol 5-phosphate-loaded-apoptotic body-like liposomes for Mycobacterium abscessus infections management in people with cystic fibrosis 13
Totale 28.491
Categoria #
all - tutte 69.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 0 0 0 0 0 0 0 0 0 0 55
2021/2022936 25 64 35 28 17 69 61 165 76 86 59 251
2022/20231.213 97 110 42 153 150 247 92 73 118 4 88 39
2023/20241.309 68 16 19 157 141 357 151 101 69 50 66 114
2024/20252.258 152 383 230 167 107 193 218 106 214 179 168 141
2025/20264.028 330 227 422 411 408 159 462 466 394 336 286 127
Totale 28.491